back to webinars
PPH16: Miriam Moscovitch-lopatin, Massgeneral Institute For Neurodegenerative Disease
date
26 September 2016time & location
2:00PM, VirtualMiriam Moscovitch-Lopatin, from MassGeneral Institute for Neurodegenerative Disease presented a longitudinal pre-cell biomarker study she conducted on an ultrasensitive Simoa immunoassay for quantifying BDNF levels in cerebral spinal fluid in early Huntington’s disease at the inaugural Powering Precision Health Summit 2016.